These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12760889)

  • 21. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplacental passage of vancomycin in noninfected term pregnant women.
    Laiprasert J; Klein K; Mueller BA; Pearlman MD
    Obstet Gynecol; 2007 May; 109(5):1105-10. PubMed ID: 17470590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneal penetration of doripenem after intravenous administration in abdominal-surgery patients.
    Ikawa K; Morikawa N; Urakawa N; Ikeda K; Ohge H; Sueda T
    J Antimicrob Chemother; 2007 Dec; 60(6):1395-7. PubMed ID: 17884833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery.
    Kitzes-Cohen R; Farin D; Piva G; Ivry S; Sharony R; Amar R; Uretzky G
    Ther Drug Monit; 2000 Dec; 22(6):661-7. PubMed ID: 11128233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
    Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
    Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluctuations in vancomycin CNS tissue concentrations following intermittent and continuous infusions in the rat.
    Luer MS; Neill KK; Gurley BJ; Shannon ML; Killian AD; Rodvold KA
    Neurol Res; 2004 Apr; 26(3):312-5. PubMed ID: 15142325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy.
    Chen K; Wu Y; Wang Q; Wang J; Li X; Zhao Z; Zhou J
    J Crit Care; 2015 Feb; 30(1):218.e1-5. PubMed ID: 25449880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Importance of Individualized Vancomycin Dosing to Ensure Optimal Exposure Early in Therapy.
    Zasowski EJ; Lodise TP
    J Clin Pharmacol; 2018 Sep; 58(9):1131-1133. PubMed ID: 30024648
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuous Versus Intermittent Infusion of Vancomycin and the Risk of Acute Kidney Injury in Critically Ill Adults: A Systematic Review and Meta-Analysis.
    Flannery AH; Bissell BD; Bastin MT; Morris PE; Neyra JA
    Crit Care Med; 2020 Jun; 48(6):912-918. PubMed ID: 32317590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing the Clinical Use of Vancomycin.
    Álvarez R; López Cortés LE; Molina J; Cisneros JM; Pachón J
    Antimicrob Agents Chemother; 2016 May; 60(5):2601-9. PubMed ID: 26856841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.
    Hong LT; Goolsby TA; Sherman DS; Mueller SW; Reynolds P; Cava L; Neumann R; Kiser TH
    J Crit Care; 2015 Oct; 30(5):1153.e1-6. PubMed ID: 26239323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.
    Wysocki M; Delatour F; Faurisson F; Rauss A; Pean Y; Misset B; Thomas F; Timsit JF; Similowski T; Mentec H; Mier L; Dreyfuss D
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2460-7. PubMed ID: 11502515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin intermittent dosing versus continuous infusion for treatment of ventilator-associated pneumonia in trauma patients.
    Schmelzer TM; Christmas AB; Norton HJ; Heniford BT; Sing RF
    Am Surg; 2013 Nov; 79(11):1185-90. PubMed ID: 24165255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice.
    Elbarbry F
    Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):259-268. PubMed ID: 29260505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.
    Gwee A; Cranswick N; Donath SM; Hunt R; Curtis N
    BMJ Open; 2018 Nov; 8(11):e022603. PubMed ID: 30391914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
    James JK; Palmer SM; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 1996 Mar; 40(3):696-700. PubMed ID: 8851595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects.
    Ampe E; Delaere B; Hecq JD; Tulkens PM; Glupczynski Y
    Int J Antimicrob Agents; 2013 May; 41(5):439-46. PubMed ID: 23523733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
    Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
    J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.